![Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009–2013 - Clinical Microbiology and Infection Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009–2013 - Clinical Microbiology and Infection](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7a6eb8bb-7e23-4435-9131-eb04fdded720/gr1.jpg)
Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009–2013 - Clinical Microbiology and Infection
![Drug-resistant tuberculosis: what is the situation, what are the needs to roll it back | AMR Control Drug-resistant tuberculosis: what is the situation, what are the needs to roll it back | AMR Control](http://resistancecontrol.info/wp-content/uploads/2017/07/Screen-Shot-2017-09-04-at-10.24.13.png)
Drug-resistant tuberculosis: what is the situation, what are the needs to roll it back | AMR Control
![Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis - Ünsal - Journal of Thoracic Disease Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis - Ünsal - Journal of Thoracic Disease](https://cdn.amegroups.cn/journals/pbpc/files/journals/2/articles/1289/public/1289-PB5-R1.png)
Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis - Ünsal - Journal of Thoracic Disease
![Infographic: Drug-resistant TB: How many pills does it take? | Médecins Sans Frontières Access Campaign Infographic: Drug-resistant TB: How many pills does it take? | Médecins Sans Frontières Access Campaign](https://msfaccess.org/sites/default/files/styles/msf_medium/public/2018-06/tb_infographic_14600_pills_long_scrollartboard-1.png?itok=1hJgzCb7)
Infographic: Drug-resistant TB: How many pills does it take? | Médecins Sans Frontières Access Campaign
![Treatment Outcomes and Adverse Events from a Standardized Multidrug-Resistant Tuberculosis Regimen in a Rural Setting in Angola in: The American Journal of Tropical Medicine and Hygiene Volume 101 Issue 3 (2019) Treatment Outcomes and Adverse Events from a Standardized Multidrug-Resistant Tuberculosis Regimen in a Rural Setting in Angola in: The American Journal of Tropical Medicine and Hygiene Volume 101 Issue 3 (2019)](https://www.ajtmh.org/view/journals/tpmd/101/3/full-tpmd190175f1.jpg)
Treatment Outcomes and Adverse Events from a Standardized Multidrug-Resistant Tuberculosis Regimen in a Rural Setting in Angola in: The American Journal of Tropical Medicine and Hygiene Volume 101 Issue 3 (2019)
WHO Operational Handbook on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment
![Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment - ScienceDirect Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1471489217301571-fx1.jpg)
Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment - ScienceDirect
![Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis - The Lancet Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/2abcdda1-7c59-4ad2-8881-c1beebd4a806/gr1.jpg)
Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis - The Lancet
![Resistance patterns, prevalence, and predictors of fluoroquinolones resistance in multidrug resistant tuberculosis patients Resistance patterns, prevalence, and predictors of fluoroquinolones resistance in multidrug resistant tuberculosis patients](http://www.scielo.br/img/revistas/bjid/v20n1//1413-8670-bjid-20-1-0041-gf01.jpg)
Resistance patterns, prevalence, and predictors of fluoroquinolones resistance in multidrug resistant tuberculosis patients
Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a
![Review on emergence of drug-resistant tuberculosis (MDR & XDR-TB) and its molecular diagnosis in Ethiopia - ScienceDirect Review on emergence of drug-resistant tuberculosis (MDR & XDR-TB) and its molecular diagnosis in Ethiopia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0882401018300482-gr1.jpg)
Review on emergence of drug-resistant tuberculosis (MDR & XDR-TB) and its molecular diagnosis in Ethiopia - ScienceDirect
![Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study | Infectious Diseases of Poverty | Full Text Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study | Infectious Diseases of Poverty | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40249-020-00719-x/MediaObjects/40249_2020_719_Fig2_HTML.png)
Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study | Infectious Diseases of Poverty | Full Text
![New Oral MDR-TB Treatment Shows Positive Trial Results - Potential To Change Clinical Practice & Save Lives - Health Policy Watch New Oral MDR-TB Treatment Shows Positive Trial Results - Potential To Change Clinical Practice & Save Lives - Health Policy Watch](https://healthpolicy-watch.news/wp-content/uploads/2021/03/MDR-TB.jpg)
New Oral MDR-TB Treatment Shows Positive Trial Results - Potential To Change Clinical Practice & Save Lives - Health Policy Watch
![Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid - International Journal of Infectious Diseases Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid - International Journal of Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/d2041c3c-89f5-4341-9ab4-a250899b94fe/gr1.jpg)
Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid - International Journal of Infectious Diseases
![Clinical risk factors associated with multidrug-resistant tuberculosis (MDR- TB) in Mali - International Journal of Infectious Diseases Clinical risk factors associated with multidrug-resistant tuberculosis (MDR- TB) in Mali - International Journal of Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7f2058c2-a2d9-4df5-9dbd-49fa0a9f9793/gr1.jpg)